Welcome to edition 484 of Insider Weekends. Insider buying declined significantly last week with insiders purchasing $57.61 million of stock last week compared to $252.96 million in the week prior. Selling also declined with insiders selling $683.67 million of stock last week compared to $1.20 billion in the week prior.
With the end of the quarter upon us and most companies entering their pre-earnings quiet periods, insider activity is likely to remain lackluster for a few weeks.
Sell/Buy Ratio: The insider Sell/Buy ratio is calculated by dividing the total insider sales in a given week by total insider purchases that week. The adjusted ratio for last week went up to 11.87. In other words, insiders sold almost 12 times as much stock as they purchased. The Sell/Buy ratio this week compares unfavorably with the prior week, when the ratio stood at 4.75.
Note: As mentioned in the first post in this series, certain industries have their preferred metrics such as same store sales for retailers, funds from operations (FFO) for REITs and revenue per available room (RevPAR) for hotels that provide a better basis for comparison than simple valuation metrics. However metrics like Price/Earnings, Price/Sales and Enterprise Value/EBITDA included below should provide a good starting point for analyzing the majority of stocks.
Notable Insider Buys:
1. Scientific Games Corporation (SGMS): $20.80
Director Ronald O. Perelman acquired 200,000 shares of this gaming company, paying $21.90 per share for a total amount of $4.38 million. These shares were purchased indirectly through a trust.
Mr. Perelman also purchased 100,000 shares earlier this mont and 305,000 shares in June of this year. He was an aggressive buyer last December when the stock was trading in the high teens after a general market decline. We wrote the following after his December 2018 purchases,
The seventy five year old corporate raider of the 1980s turned philanthropist was active this December making multiple purchases in three stocks including Scientific Games, Revlon (REV) and vTv Therapeutics (VTVT). While Scientific Games and Revlon have market caps of over $1 billion, vTv is a tiny microcap stock, which shot up 120.39% last Friday on volume that was 243 times the volume of shares traded on Thursday. I did not see any other news for vTv and this huge move appears to be on account of Mr. Perelman’s purchase through his holding company MacAndrews & Forbes Incorporated. We saw a similar huge move in VTVT in October following Mr. Perelman’s purchases but the stock eventually gave back most of those gains.
You can view the list of recent insider transactions for Scientific Games Corporation here.
P/E: N/A | Forward P/E: 27.02 | Industry P/E: N/A |
P/S: 0.57 | Price/Book: N/A | EV/EBITDA: 10.2 |
Market Cap: $1.94B | Avg. Daily Volume: 1,165,942 | 52 Week Range: $14.79 – $29.95 |
2. Interface, Inc. (TILE): $14.59
Director Christopher G. Kennedy acquired 49,000 shares of this modular flooring company, paying $13.74 per share for a total amount of $673,337. Mr. Kennedy increased his stake by 55.86% to 136,721 shares with this purchase.
It appears that directors of three different flooring companies include two manufacturers and one retailer appear to be bullish on the prospects of the flooring business even as the stocks of all three companies have had a rough year as you can see from the chart below. All three appear to be in an uptrend in recent week as investors rotate out of growth and into value names.
All three companies trade for less than 10 times EBITDA but their biggest challenge appears to be top line growth, or lack thereof. The double digit top line growth at Interface is driven by an acquisition by the company last year. Mohawk (MHK) has the best operating margins, lowest valuation and least leverage balance sheet of the three. Unfortunately it is barely growing and has exposure to China both as a country it sources from and sells to.
You can view the list of recent insider transactions for Interface, Inc. here.
P/E: 17.16 | Forward P/E: 8.34 | Industry P/E: N/A |
P/S: 0.65 | Price/Book: 2.42 | EV/EBITDA: 8.09 |
Market Cap: $852.54M | Avg. Daily Volume: 389,157 | 52 Week Range: $10.37 – $23.5 |
3. GameStop Corp. (GME): $5.34
Shares of this video game retailer were acquired by 4 insiders:
GameStop, the classic value stock (or value trap depending on whom you ask) declined most of this year but appears to have bottomed in early September shortly before the company reported fiscal Q2 results that saw its top line shrink nearly 14.35% to $1.29 billion and a non-GAAP loss of 32 cents.
With the exception of collectibles, revenue declined in every other category. There are several reasons for the decline including a late cycle console market that caused a 41% decline in new hardware sales and a shift away from physical media to game downloads. The low teen same-store-sales decline forecast appears bleak but the company expects annual operating cash flow to improve by more than $200 million compared to approximately $100 million from a prior forecast.
What is interesting this time around is that we are seeing a cluster of insider purchases. Through this multi-year decline at GameStop, insiders have not stepped up to buy the stock except for an EVP picking up 10,000 shares in September 2016. You have to go back all the way to May 2012 to see two other insider purchases by the then CEO and the President of the company. GameStop picked a retail veteran, George Sherman, as its new CEO in March of this year.
You can view the list of recent insider transactions for GameStop Corp. here.
P/E: N/A | Forward P/E: 4.68 | Industry P/E: N/A |
P/S: 0.06 | Price/Book: 0.6 | EV/EBITDA: 3.79 |
Market Cap: $483.04M | Avg. Daily Volume: 7,973,298 | 52 Week Range: $3.15 – $16.9 |
4. IGM Biosciences, Inc. (IGMS): $17.91
Director Jakob Haldor Topsoe acquired 18,340 shares of this biotech company, paying $21.68 per share for a total amount of $397,604. Mr. Topsoe increased his stake by 50.84% to 54,415 shares with this purchase.
You can view the list of recent insider transactions for IGM Biosciences, Inc. here.
P/E: N/A | Forward P/E: N/A | Industry P/E: N/A |
P/S: N/A | Price/Book: N/A | EV/EBITDA: -2.77 |
Market Cap: $546.84M | Avg. Daily Volume: 363,425 | 52 Week Range: $16.56 – $24.57 |
5. Gossamer Bio, Inc. (GOSS): $17.19
Shares of this biotech company were acquired by 4 insiders:
You can view the list of recent insider transactions for Gossamer Bio, Inc. here.
P/E: N/A | Forward P/E: -4.84 | Industry P/E: N/A |
P/S: N/A | Price/Book: 2.35 | EV/EBITDA: -4.46 |
Market Cap: $1.13B | Avg. Daily Volume: 435,112 | 52 Week Range: $15.59 – $25.06 |
You can view the full list of purchases from this Insider Buying page.
Notable Insider Sales:
1. Facebook, Inc. (FB): $177.1
Shares of Facebook were sold by 2 insiders:
You can view the list of recent insider transactions for Facebook, Inc. here.
P/E: 29.95 | Forward P/E: 18.64 | Industry P/E: N/A |
P/S: 8.07 | Price/Book: 5.69 | EV/EBITDA: 17.71 |
Market Cap: $505.26B | Avg. Daily Volume: 14,311,481 | 52 Week Range: $123.02 – $208.66 |
2. Morningstar, Inc. (MORN): $146.21
Executive Chairman Joseph D. Mansueto sold 40,761 shares of this investment research services provider for $158.44, generating $6.46 million from the sale.
You can view the list of recent insider transactions for Morningstar, Inc. here.
P/E: 36.11 | Forward P/E: 51.48 | Industry P/E: N/A |
P/S: 5.92 | Price/Book: 6.23 | EV/EBITDA: 23.45 |
Market Cap: $6.25B | Avg. Daily Volume: 88,201 | 52 Week Range: $99.67 – $162.53 |
3. Jabil Inc. (JBL): $35.23
Shares of this electronic manufacturing services provider were sold by 6 insiders:
You can view the list of recent insider transactions for Jabil Inc. here.
P/E: 32.32 | Forward P/E: 8.83 | Industry P/E: N/A |
P/S: 0.22 | Price/Book: 2.9 | EV/EBITDA: 4.66 |
Market Cap: $5.3B | Avg. Daily Volume: 1,254,087 | 52 Week Range: $21.49 – $35.96 |
4. Goosehead Insurance, Inc (GSHD): $48.76
CEO Mark Evan Jones sold 62,015 shares of this insurance company for $49.02, generating $3.04 million from the sale. These shares were sold indirectly by a trust.
You can view the list of recent insider transactions for Goosehead Insurance, Inc here.
P/E: 192.73 | Forward P/E: 73.88 | Industry P/E: N/A |
P/S: 24.32 | Price/Book: 9.58 | EV/EBITDA: 35.62 |
Market Cap: $1.77B | Avg. Daily Volume: 179,956 | 52 Week Range: $20.49 – $51.98 |
5. salesforce.com, inc. (CRM): $148.26
Shares of this software application company were sold by 9 insiders:
You can view the list of recent insider transactions for salesforce.com, inc. here.
P/E: 123.14 | Forward P/E: 47.83 | Industry P/E: N/A |
P/S: 8.83 | Price/Book: 6.74 | EV/EBITDA: 64.92 |
Market Cap: $130.02B | Avg. Daily Volume: 6,415,559 | 52 Week Range: $113.6 – $167.56 |
You can view the full list of sales from this Insider Sales page.
Disclaimer: Please do your own due diligence before buying or selling any securities mentioned in this article. We do not warrant the completeness or accuracy of the content or data provided in this article.
Connect with me on LinkedIn: http://www.linkedin.com/in/asifsuria or follow me on Twitter @asifsuria